Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 428)
Posted On: 08/15/2021 9:31:42 PM
Post# of 36570
Avatar
Posted By: gd4nthing
Re: rjs9787 #31420
Is this the part you are referring to that sounds a lot like what we are doing?

Is this technically possible?

It is feasible by identifying the regions of the Spike protein that are responsible for the production of the “facilitating” antibodies and removing them from the final structure of the vaccine Spike protein. This requires prior work to identify the “facilitating” B epitopes.
Another approach is to produce synthetic vaccines based on peptides (fragments of the Spike protein) that mimic the protective B and T epitopes of the Spike protein.

https://frenchdailynews.com/society/3205-covi...he-vaccine













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site